Log in to your account:
Bristol-Myers Squibb (BMY) Announces Long-Term Survival Results from Opdivo in Lung Cancer
April 2, 2019 1:03 PM
Bristol-Myers Squibb Company (NYSE: BMY) today announced results from pooled analyses of survival data ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Bristol-Myers Squibb Announces Long-Term Survival Results from Pooled Analyses of Opdivo (nivolumab) in Previously-Treated Non-Small Cell Lung Cancer Patients
April 2, 2019 1:00 PM